Ketoconazole is NOT Appropriate for Ringworm in a 12-Year-Old
Oral ketoconazole should not be used for treating tinea corporis (ringworm) in a 12-year-old child due to its withdrawal from use in the UK and Europe in 2013 because of hepatotoxicity risk, despite demonstrated efficacy. 1
Why Ketoconazole is Contraindicated
The British Association of Dermatologists guidelines explicitly state that oral ketoconazole was withdrawn from use in the UK and Europe in 2013 due to a "sufficiently poor side-effect profile (especially the risk of hepatotoxicity)." 1 While ketoconazole at doses of 33-66 mg/kg daily showed comparable efficacy to griseofulvin in the past, resolution of symptoms was slower and the safety concerns outweighed any benefits. 1
Important Distinction: Topical vs. Oral Formulations
- Topical ketoconazole 2% cream is FDA-approved and appropriate for tinea corporis 2
- Oral ketoconazole is what was withdrawn due to hepatotoxicity concerns
- For tinea corporis (body ringworm), topical therapy alone is typically sufficient, unlike tinea capitis (scalp ringworm) which requires systemic treatment
Recommended Treatment Approach for Tinea Corporis in a 12-Year-Old
Use topical antifungal therapy as first-line treatment:
Topical Options (FDA-Approved)
- Ketoconazole 2% cream: Apply once daily for 2 weeks 2
- Terbinafine 1% cream: Once daily for 1 week (more effective than ketoconazole topically) 3
- Other azoles (clotrimazole, miconazole): Twice daily for 2-4 weeks
When Systemic Therapy is Needed
If the infection is extensive or unresponsive to topical treatment, consider oral agents:
- Terbinafine (for Trichophyton species): 2-4 weeks based on weight
- Griseofulvin (for Microsporum species): 6-8 weeks
- Itraconazole or fluconazole: Alternative second-line agents 4
Clinical Pearls
Key differences from tinea capitis: The evidence provided primarily addresses tinea capitis (scalp ringworm), which requires systemic therapy. 1 Tinea corporis (body ringworm) typically responds well to topical therapy alone and does not require the aggressive systemic approach needed for scalp infections.
Topical ketoconazole is safe and effective for tinea corporis when used as a cream formulation, showing 82% marked or excellent response rates in clinical trials. 5 However, terbinafine 1% topical may be superior, achieving 94% mycological cure versus 69% for ketoconazole cream. 3
Avoid the pitfall of confusing topical ketoconazole (appropriate) with oral ketoconazole (withdrawn/contraindicated). The hepatotoxicity concerns apply specifically to systemic use.